Systems-level analysis of innate immunity

Annual Review of Immunology

Volumn 32, Issue , 2014, Pages 547-577

  Zak, Daniel E ^a   Tam, Vincent C ^a   Aderem, Alan ^a  

^a Seattle BioMed   (United States)

Author keywords

Influenza; Lipidomics; Proteomics; Systems biology; Systems vaccinology; Transcriptomics

Indexed keywords

BCG VACCINE; INFLUENZA VACCINE;

ADAPTIVE IMMUNITY; ANTIVIRAL ACTIVITY; FRANCISELLA TULARENSIS; GENE REGULATORY NETWORK; GENOME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA; INNATE IMMUNITY; LIPIDOMICS; MALARIA; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SALMONELLA; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TUBERCULOSIS;

ANIMALS; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; HUMANS; IMMUNITY, INNATE; SYSTEMS BIOLOGY; VACCINES;

EID: 84896928497     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-032713-120254     Document Type: Review

References (160)

1. Ramsey SA, Klemm SL, Zak DE, Kennedy KA, Thorsson V, et al. 2008. Uncovering a macrophage transcriptional program by integrating evidence from motif scanning and expression dynamics. PLoS Comput. Biol. 4:e1000021
2. Germain RN, Meier-Schellersheim M, Nita-Lazar A, Fraser ID. 2011. Systems biology in immunology: a computational modeling perspective. Annu. Rev. Immunol. 29:527-85
3. Poultney CS, Greenfield A, Bonneau R. 2012. Integrated inference and analysis of regulatory networks from multi-level measurements. Methods Cell Biol. 110:19-56
4. Ghosh S, Matsuoka Y, Asai Y, Hsin KY, Kitano H. 2011. Software for systems biology: from tools to integrated platforms. Nat. Rev. Genet. 12:821-32
5. De Smet R, Marchal K. 2010. Advantages and limitations of current network inference methods. Nat. Rev. Microbiol. 8:717-29
6. Ciofani M, Madar A, Galan C, Sellars M, Mace K, et al. 2012. A validated regulatory network for Th17 cell specification. Cell 151:289-303
7. Newell EW, Sigal N, Bendall SC, Nolan GP, Davis MM. 2012. Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes. Immunity 36:142-52
8. Zhang JA, Mortazavi A, Williams BA, Wold BJ, Rothenberg EV. 2012. Dynamic transformations of genome-wide epigenetic marking and transcriptional control establish T cell identity. Cell 149:467-82
9. O'Neill LA, Bowie AG. 2007. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7:353-64
10. Ishii KJ, Koyama S, Nakagawa A, Coban C, Akira S. 2008. Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 3:352-63
11. Paludan SR, Bowie AG. 2013. Immune sensing of DNA. Immunity 38:870-80
12. Underhill DM, Ozinsky A. 2002. Phagocytosis of microbes: complexity in action. Annu. Rev. Immunol. 20:825-52
13. Trinchieri G, Sher A. 2007. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 7:179-90
14. Goodridge HS,Underhill DM.2008. Fungal recognition byTLR2 and Dectin-1. Handb. Exp. Pharmacol. 183:87-109
15. Aderem AA, Cohen DS, Wright SD, Cohn ZA. 1986. Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites. J. Exp. Med. 164:165-79
16. Blander JM, Medzhitov R. 2006. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440:808-12
17. Mohr S, Bakal C, Perrimon N. 2010. Genomic screening with RNAi: results and challenges. Annu. Rev. Biochem. 79:37-64
18. Beutler B, Moresco EM. 2008. The forward genetic dissection of afferent innate immunity. Curr. Top. Microbiol. Immunol. 321:3-26
19. Cook MC, Vinuesa CG, Goodnow CC. 2006. ENU-mutagenesis: insight into immune function and pathology. Curr. Opin. Immunol. 18:627-33
20. Bolouri H, Davidson EH. 2003. Transcriptional regulatory cascades in development: initial rates, not steady state, determine network kinetics. Proc. Natl. Acad. Sci. USA 100:9371-76
21. Smith J, Theodoris C, Davidson EH. 2007. A gene regulatory network subcircuit drives a dynamic pattern of gene expression. Science 318:794-97
22. Gilchrist M, Thorsson V, Li B, Rust AG, Korb M, et al. 2006. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441:173-78
23. Litvak V, Ramsey SA, Rust AG, Zak DE, Kennedy KA, et al. 2009. Function of C/EBP in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals. Nat. Immunol. 10:437-43
24. Alon U. 2007. Network motifs: theory and experimental approaches. Nat. Rev. Genet. 8:450-61
25. Litvak V, Ratushny AV, Lampano AE, Schmitz F, Huang AC, et al. 2012. A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses. Nature 490:421-25
26. Seymour RE, Hasham MG, Cox GA, Shultz LD, Hogenesch H, et al. 2007. Spontaneous mutations in themouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis. Genes Immun. 8:416-21
27. Siggs OM, Berger M, Krebs P, Arnold CN, Eidenschenk C, et al. 2010. A mutation of Ikbkg causes immune deficiency without impairing degradation of IκBα. Proc. Natl. Acad. Sci. USA 107:3046-51
28. Zak DE, Schmitz F, Gold ES, Diercks AH, Peschon JJ, et al. 2011. Systems analysis identifies an essential role for SHANK-Associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses. Proc. Natl. Acad. Sci. USA 108:11536-41
29. Amit I,GarberM,ChevrierN, Leite AP,Donner Y, et al. 2009. Unbiased reconstruction of amammalian transcriptional network mediating pathogen responses. Science 326:257-63
30. Kulkarni MM. 2011. Digital multiplexed gene expression analysis using the NanoString nCounter system. Curr. Protoc. Mol. Biol. 94:25B.10
31. Garber M, Yosef N, Goren A, Raychowdhury R, Thielke A, et al. 2012. A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals. Mol. Cell 47:810-22
32. Stender JD, Glass CK. 2013. Epigenomic control of the innate immune response. Curr. Opin. Pharmacol. 13:582-87
33. KaikkonenMU, SpannNJ, Heinz S,Romanoski CE, Allison KA, et al. 2013. Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol. Cell 51:310-25
34. Chevrier N, Mertins P, Artyomov MN, Shalek AK, Iannacone M, et al. 2011. Systematic discovery of TLR signaling components delineates viral-sensing circuits. Cell 147:853-67
35. de Veer MJ, Holko M, Frevel M, Walker E, Der S, et al. 2001. Functional classification of interferonstimulated genes identified using microarrays. J. Leukoc. Biol. 69:912-20
36. Schoggins JW,Wilson SJ, Panis M, Murphy MY, Jones CT, et al. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481-85
37. Versteeg GA, Rajsbaum R, Sanchez-Aparicio MT,Maestre AM, Valdiviezo J, et al. 2013. The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors. Immunity 38:384-98
38. McNab FW, Rajsbaum R, Stoye JP, O'Garra A. 2011. Tripartite-motif proteins and innate immune regulation. Curr. Opin. Immunol. 23:46-56
39. Ozato K, Shin DM, Chang TH, Morse HC III. 2008. TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. Immunol. 8:849-60
40. Li S, Wang L, Berman M, Kong YY, Dorf ME. 2011. Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Immunity 35:426-40
41. Lee MN, Roy M, Ong SE, Mertins P, Villani AC, et al. 2013. Identification of regulators of the innate immune response to cytosolic DNA and retroviral infection by an integrative approach. Nat. Immunol. 14:179-85
42. Elkon R, Linhart C, Halperin Y, Shiloh Y, Shamir R. 2007. Functional genomic delineation of TLRinduced transcriptional networks. BMC Genomics 8:394
43. Ramsey SA, Knijnenburg TA, Kennedy KA, Zak DE, Gilchrist M, et al. 2010. Genome-wide histone acetylation data improve prediction of mammalian transcription factor binding sites. Bioinformatics 26:2071-75
44. Li F, Thiele I, Jamshidi N, Palsson BO. 2009. Identification of potential pathway mediation targets in Toll-like receptor signaling. PLoS Comput. Biol. 5:e1000292
45. Bordbar A, Mo ML, Nakayasu ES, Schrimpe-Rutledge AC, Kim YM, et al. 2012. Model-driven multiomic data analysis elucidates metabolic immunomodulators of macrophage activation. Mol. Syst. Biol. 8:558
46. Bordbar A, Lewis NE, Schellenberger J, Palsson BO, Jamshidi N. 2010. Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructions. Mol. Syst. Biol. 6:422
47. Kalisky T, Blainey P, Quake SR. 2011. Genomic analysis at the single-cell level. Annu. Rev. Genet. 45:431-45
48. Kalisky T, Quake SR. 2011. Single-cell genomics. Nat. Methods 8:311-14
49. Bandura DR, Baranov VI, Ornatsky OI, Antonov A, Kinach R, et al. 2009. Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry. Anal. Chem. 81:6813-22
50. Bendall SC, Nolan GP. 2012. From single cells to deep phenotypes in cancer. Nat. Biotechnol. 30:639-47
51. Diercks AH, Ozinsky A, Hansen CL, Spotts JM, Rodriguez DJ, Aderem A. 2009. A microfluidic device for multiplexed protein detection in nano-liter volumes. Anal. Biochem. 386:30-35
52. Gottschalk RA, Martins AJ, Sjoelund VH, Angermann BR, Lin B, Germain RN. 2012. Recent progress using systems biology approaches to better understand molecular mechanisms of immunity. Semin. Immunol. 25:201-8
53. Shalek AK, Satija R, Adiconis X, Gertner RS, Gaublomme JT, et al. 2013. Single-cell transcriptomics reveals bimodality in expression and splicing in immune cells. Nature 498:236-40
54. Ma C, Fan R, Ahmad H, Shi Q, Comin-Anduix B, et al. 2011. A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells. Nat. Med. 17:738-43
55. Varadarajan N, Julg B, Yamanaka YJ, Chen H, Ogunniyi AO, et al. 2011. A high-throughput singlecell analysis of human CD8+ T cell functions reveals discordance for cytokine secretion and cytolysis. J. Clin. Investig. 121:4322-31
56. Bodenmiller B, Zunder ER, Finck R, Chen TJ, Savig ES, et al. 2012. Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators. Nat. Biotechnol. 30:858-67
57. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, et al. 2010. An interferon-inducible neutrophildriven blood transcriptional signature in human tuberculosis. Nature 466:973-77
58. Weiner J, Maertzdorf J, Kaufmann SH. 2013. The dual role of biomarkers for understanding basic principles and devising novel intervention strategies in tuberculosis. Ann. N.Y. Acad. Sci. 1283:22-29
59. Palermo RE, FullerDH. 2013. 'Omics investigations ofHIV and SIV pathogenesis and innate immunity. Curr. Top. Microbiol. Immunol. 363:87-116
60. Bosinger SE, Jacquelin B, Benecke A, Silvestri G, Muller-Trutwin M. 2012. Systems biology of natural simian immunodeficiency virus infections. Curr. Opin. HIV AIDS 7:71-78
61. Peretz Y, CameronC, Sekaly RP. 2012. Dissecting the HIV-specific immune response: a systems biology approach. Curr. Opin. HIV AIDS 7:17-23
62. Walters KA, Olsufka R, Kuestner RE, Cho JH, Li H, et al. 2013. Francisella tularensis subsp. tularensis induces a unique pulmonary inflammatory response: role of bacterial gene expression in temporal regulation of host defense responses. PLoS ONE 8:e62412
63. Thompson LJ, Dunstan SJ, Dolecek C, Perkins T,House D, et al. 2009. Transcriptional response in the peripheral blood of patients infected with Salmonella enterica serovar Typhi. Proc. Natl. Acad. Sci. USA 106:22433-38
64. Ravi LI, Li L, Sutejo R, Chen H, Wong PS, et al. 2013. A systems-based approach to analyse the host response in murine lung macrophages challenged with respiratory syncytial virus. BMC Genomics 14:190
65. Jagger BW, Wise HM, Kash JC, Walters KA, Wills NM, et al. 2012. An overlapping protein-coding region in influenza A virus segment 3 modulates the host response. Science 337:199-204
66. Kash JC, Walters KA, Davis AS, Sandouk A, Schwartzman LM, et al. 2011. Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses. mBio 2:e00172-11
67. Tisoncik JR,Korth MJ, Simmons CP, Farrar J,MartinTR, KatzeMG. 2012. Into the eye of the cytokine storm. Microbiol. Mol. Biol. Rev. 76:16-32
68. ImaiM,Watanabe T, Hatta M, Das SC, OzawaM, et al. 2012. Experimental adaptation of an influenza H5 haemagglutinin (HA) confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486:420-28
69. Herfst S, Schrauwen EJA, Linster M, Chutinimitkul S, de Wit E, et al. 2012. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336:1534-41
70. Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, et al. 2006. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443:578-81
71. Cilloniz C, Shinya K, Peng X, Korth MJ, Proll SC, et al. 2009. Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog. 5:e1000604
72. Askovich PS, Sanders CJ, Rosenberger CM, Diercks AH, Dash P, et al. 2013. Differential host response, rather than early viral replication efficiency, correlates with pathogenicity caused by influenza viruses. PLoS ONE 8:e74863
73. Brandes M, Klauschen F, Kuchen S, Germain RN. 2013. A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell 154:197-212
74. Li Y, Chan EY, Li J, Ni C, Peng X, et al. 2010. MicroRNA expression and virulence in pandemic influenza virus-infected mice. J. Virol. 84:3023-32
75. Peng X, Gralinski L, Ferris MT, Frieman MB, Thomas MJ, et al. 2011. Integrative deep sequencing of the mouse lung transcriptome reveals differential expression of diverse classes of small RNAs in response to respiratory virus infection. mBio 2:e00198-11
76. Rosenberger CM, Podyminogin RL, Navarro G, Zhao GW, Askovich PS, et al. 2012. miR-451 regulates dendritic cell cytokine responses to influenza infection. J. Immunol. 189:5965-75
77. Baas T, Baskin CR,DiamondDL, Garca-Sastre A, Bielefeldt-OhmannH, et al. 2006. Integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomics. J. Virol. 80:10813-28
78. Brown JN, Palermo RE, Baskin CR,Gritsenko M, Sabourin PJ, et al. 2010. Macaque proteome response to highly pathogenic avian influenza and 1918 reassortant influenza virus infections. J. Virol. 84:12058-68
79. Kroeker AL, Ezzati P, Halayko AJ, Coombs KM. 2012. Response of primary human airway epithelial cells to influenza infection: a quantitative proteomic study. J. Proteome Res. 11:4132-46
80. Lietzen N, Ohman T, Rintahaka J, Julkunen I, Aittokallio T, et al. 2011. Quantitative subcellular proteome and secretome profiling of influenza A virus-infected human primary macrophages. PLoS Pathog. 7:e1001340
81. Cheung CY, Chan EY, Krasnoselsky A, Purdy D, Navare AT, et al. 2012. H5N1 virus causes significant perturbations in host proteome very early in influenza virus-infected primary human monocyte-derived macrophages. J. Infect. Dis. 206:640-45
82. Shapira SD, Gat-Viks I, Shum BOV, Dricot A, de Grace MM, et al. 2009. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139:1255-67
83. Tam VC, Quehenberger O, Oshansky CM, Suen R, Armando AM, et al. 2013. Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation. Cell 154:213-27
84. Morita M, Kuba K, Ichikawa A, Nakayama M, Katahira J, et al. 2013. The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell 153:112-25
85. Lawrence T, Willoughby DA, Gilroy DW. 2002. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat. Rev. Immunol. 2:787-95
86. Quehenberger O, Dennis EA. 2011. The human plasma lipidome. N. Engl. J. Med. 365:1812-23
87. Serhan CN, Krishnamoorthy S, Recchiuti A, Chiang N. 2011. Novel anti-inflammatory-pro-resolving mediators and their receptors. Curr. Top. Med. Chem. 11:629-47
88. Serhan CN, Chiang N, Van Dyke TE. 2008. Resolving inflammation: dual anti-inflammatory and proresolution lipid mediators. Nat. Rev. Immunol. 8:349-61
89. Buczynski M, Dumlao D, Dennis E. 2009. An integrated omics analysis of eicosanoid biology. J. Lipid Res. 6:1015-38
90. Norris PC, Dennis EA. 2012. Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling. Proc. Natl. Acad. Sci. USA 109:8517-22
91. Yang R, Chiang N, Oh SF, Serhan CN
92. Karlas A, Machuy N, Shin Y, Pleissner K-P, Artarini A, et al. 2010. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463:818-22
93. Munier S, Rolland T, Diot C, Jacob Y, Naffakh N. 2013. Exploration of binary virus-host interactions using an infectious protein complementation assay. Mol. Cell. Proteomics 12:2845-55
94. Zak DE, Aderem A. 2012. Overcoming limitations in the systems vaccinology approach: a pathway for accelerated HIV vaccine development. Curr. Opin. HIV AIDS 7:58-63
95. Pulendran B, Li S, Nakaya HI. 2010. Systems vaccinology. Immunity 33(4):516-29
96. Andersen-Nissen E, Heit A, McElrath MJ. 2012. Profiling immunity to HIV vaccines with systems biology. Curr. Opin. HIV AIDS 7:32-37
97. Rappuoli R, Aderem A. 2011. A 2020 vision for vaccines against HIV, tuberculosis and malaria. Nature 473:463-69
98. Koff WC, Burton DR, Johnson PR, Walker BD, King CR, et al. 2013. Accelerating next-generation vaccine development for global disease prevention. Science 340(6136):1232910
99. Mooney M, McWeeney S, Sekaly RP. 2013. Systems immunogenetics of vaccines. Semin. Immunol. 25(2):124-29
100. Plotkin SA. 2008. Vaccines: correlates of vaccine-induced immunity. Clin. Infect. Dis. 47(3): 401-9
101. Querec T, Bennouna S, Alkan S, Laouar Y,Gorden K, et al. 2006. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J. Exp. Med. 203:413-24
102. Lindsay RW, Darrah PA, Quinn KM, Wille-Reece U, Mattei LM, et al. 2010. CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent onCD11c+ dendritic cells but show redundancy in their requirement ofTLRand nucleotide-binding oligomerization domainlike receptor signaling. J. Immunol. 185:1513-21
103. Delaloye J, Roger T, Steiner-Tardivel QG, Le Roy D, Knaup Reymond M, et al. 2009. Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog. 5:e1000480
104. Baum LL. 2010. Role of humoral immunity in host defense against HIV. Curr. HIV/AIDS Rep. 7:11-18
105. Seder RA, Darrah PA, Roederer M. 2008. T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 8:247-58
106. FlatzL,RoychoudhuriR,Honda M, Filali-Mouhim A, Goulet JP, et al. 2011. Single-cell gene-expression profiling reveals qualitatively distinct CD8 T cells elicited by different gene-based vaccines. Proc. Natl. Acad. Sci. USA 108:5724-29
107. Baum PD, Venturi V, Price DA. 2012. Wrestling with the repertoire: the promise and perils of next generation sequencing for antigen receptors. Eur. J. Immunol. 42:2834-39
108. Autran B, Descours B, Avettand-Fenoel V, Rouzioux C. 2011. Elite controllers as a model of functional cure. Curr. Opin. HIV AIDS 6:181-87
109. Walker BD. 2007. Elite control of HIV infection: implications for vaccines and treatment. Top. HIV Med. 15:134-36
110. Thomas PG, Doherty PC. 2009. Rules to 'prime' by. Nat. Immunol. 10:14-16
111. Brooks JPL, Lee EK. 2008. Analysis of the consistency of a mixed integer programming-based multicategory constrained discriminant model. Ann. Oper. Res. 174:147-68
112. Querec TD, Akondy RS, Lee EK, Cao W, Nakaya HI, et al. 2009. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10:116-25
113. Nakaya HI,Wrammert J, LeeEK, Racioppi L, Marie-Kunze S, et al. 2011. Systems biology of vaccination for seasonal influenza in humans. Nat. Immunol. 12:786-95
114. Zou H, Hastie T. 2005. Regularization and variable selection via the elastic net. J. R. Stat. Soc. B 67:301-20
115. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, et al. 2013. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. USA 110(9):3507-12
116. Shultz LD, Brehm MA, Garcia-Martinez JV, Greiner DL. 2012. Humanized mice for immune system investigation: progress, promise and challenges. Nat. Rev. Immunol. 12:786-98
117. Chaussabel D, Quinn C, Shen J, Patel P, Glaser C, et al. 2008. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29:150-64
118. Shen-Orr SS, Tibshirani R, Khatri P, Bodian DL, Staedtler F, et al. 2010. Cell type-specific gene expression differences in complex tissues. Nat. Methods 7:287-89
119. Novershtern N, Subramanian A, Lawton LN, Mak RH, Haining WN, et al. 2011. Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell 144(2):296-309
120. Shay T, Kang J. 2013. Immunological Genome Project and systems immunology. Trends Immunol. 34(12):602-9
121. Gaucher D, Therrien R, KettafN, Angermann BR, Boucher G, et al. 2008. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205:3119-31
122. Zak DE, Andersen-Nissen E, Peterson ER, Sato A, Hamilton MK, et al. 2012. Merck Ad5/HIV induces broad innate immune activation that predicts CD8+ T-cell responses but is attenuated by preexisting Ad5 immunity. Proc. Natl. Acad. Sci. USA 109:E3503-12
123. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, et al. 2008. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebocontrolled, test-of-concept trial. Lancet 372:1881-93
124. Gray GE, AllenM,Moodie Z, Churchyard G, Bekker LG, et al. 2011. Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study. Lancet Infect. Dis. 11:507-15
125. McElrath MJ, De Rosa SC, Moodie Z, Dubey S, Kierstead L, et al. 2008. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 372:1894-905
126. RollandM,Tovanabutra S, deCamp AC, Frahm N, Gilbert PB, et al. 2011. Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial. Nat. Med. 17:366-71
127. Vahey MT,Wang Z, Kester KE, Cummings J, Heppner DG Jr, et al. 2010. Expression of genes associated with immunoproteasome processing of major histocompatibility complex peptides is indicative of protection with adjuvanted RTS,S malaria vaccine. J. Infect. Dis. 201:580-89
128. Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, et al. 2014. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat. Immunol. 15:195-204
129. Obermoser G, Presnell S, Domico K, Xu H, Wang Y, et al. 2013. Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity 38(4):831-44
130. Reif DM, Motsinger-Reif AA, McKinney BA, Rock MT, Crowe JE Jr, Moore JH. 2009. Integrated analysis of genetic and proteomic data identifies biomarkers associated with adverse events following smallpox vaccination. Genes Immun. 10(2):112-19
131. Araki K, Turner AP, Shaffer VO, Gangappa S, Keller SA, et al. 2009. mTOR regulates memory CD8 T-cell differentiation. Nature 460:108-12
132. Tan X, Sande JL, Pufnock JS, Blattman JN, Greenberg PD. 2011. Retinoic acid as a vaccine adjuvant enhances CD8+ T cell response and mucosal protection from viral challenge. J. Virol. 85:8316-27
133. Wang N, Calpe S, Westcott J, Castro W, Ma C, et al. 2010. Cutting edge: The adapters EAT-2A and -2B are positive regulators of CD244- and CD84-dependent NK cell functions in the C57BL/6 mouse. J. Immunol. 185:5683-87
134. Aldhamen YA, Appledorn DM, Seregin SS, Liu CJ, Schuldt NJ, et al. 2011. Expression of the SLAM family of receptors adapter EAT-2 as a novel strategy for enhancing beneficial immune responses to vaccine antigens. J. Immunol. 186:722-32
135. Olotu A, Fegan G, Wambua J, Nyangweso G, Awuondo KO, et al. 2013. Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure. N. Engl. J. Med. 368(12): 1111-20
136. Seder RA, Chang LJ, Enama ME, Zephir KL, Sarwar UN, et al. 2013. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341:1359-65
137. Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, et al. 2013. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebocontrolled phase 2b trial. Lancet 381(9871):1021-28
138. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, et al. 2009. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361:2209-20
139. Zak DE, Aderem A. 2009. Systems biology of innate immunity. Immunol. Rev. 227:264-82
140. Ramsey SA, Gold ES, Aderem A. 2010. A systems biology approach to understanding atherosclerosis. EMBO Mol. Med. 2:79-89
141. Kozhenkov S, Dubinina Y, SedovaM, Gupta A, Ponomarenko J, BaitalukM. 2010. BiologicalNetworks 2.0-An integrative view of genome biology data. BMC Bioinforma. 11:610
142. Breitkreutz BJ, Stark C, Tyers M. 2003. Osprey: a network visualization system. Genome Biol. 4:R22
143. Breuer K, Foroushani AK, Laird MR, Chen C, Sribnaia A, et al. 2013. InnateDB: systems biology of innate immunity and beyond-recent updates and continuing curation. Nucleic Acids Res. 41:D1228-33
144. Barsky A, Gardy JL, Hancock RE, Munzner T. 2007. Cerebral: a Cytoscape plugin for layout of and interaction with biological networks using subcellular localization annotation. Bioinformatics 23:1040-42
145. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. 2011. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27:431-32
146. Hu Z, Chang YC, Wang Y, Huang CL, Liu Y, et al. 2013. VisANT 4.0: Integrative network platform to connect genes, drugs, diseases and therapies. Nucleic Acids Res. 41:W225-31
147. CroftD,O'Kelly G,WuG, Haw R,Gillespie M, et al. 2011. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 39:D691-97
148. Nishimura D. 2001. BioCarta. Biotech Softw. Internet Rep. 2:117-20
149. Latendresse M, Paley S, Karp PD. 2012. Browsing metabolic and regulatory networks with BioCyc. Methods Mol. Biol. 804:197-216
150. Kanehisa M. 2013. Molecular network analysis of diseases and drugs in KEGG. Methods Mol. Biol. 939:263-75
151. Mi H, MuruganujanA,Thomas PD. 2013.PANTHERin 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res. 41:D377-86
152. Kelder T, van Iersel MP, Hanspers K, Kutmon M, Conklin BR, et al. 2012. WikiPathways: building research communities on biological pathways. Nucleic Acids Res. 40:D1301-7
153. Fahy E, Sud M, Cotter D, Subramaniam S. 2007. LIPID MAPS online tools for lipid research. Nucleic Acids Res. 35:W606-12
154. Cerami EG,Gross BE,Demir E, Rodchenkov I, Babur O, et al. 2011. PathwayCommons, a web resource for biological pathway data. Nucleic Acids Res. 39:D685-90
155. Kerrien S, Aranda B, Breuza L, Bridge A, Broackes-Carter F, et al. 2012. The IntActmolecular interaction database in 2012. Nucleic Acids Res. 40:D841-46
156. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, et al. 2009. Human Protein Reference Database-2009 update. Nucleic Acids Res. 37:D767-72
157. Licata L, Briganti L, Peluso D, Perfetto L, Iannuccelli M, et al. 2012. MINT, the molecular interaction database: 2012 update. Nucleic Acids Res. 40:D857-61
158. Chatr-Aryamontri A, Breitkreutz BJ, Heinicke S, Boucher L, Winter A, et al. 2013. The BioGRID interaction database: 2013 update. Nucleic Acids Res. 41:D816-23
159. Barrett T, Edgar R. 2006. Gene expression omnibus: microarray data storage, submission, retrieval, and analysis. Methods Enzymol. 411:352-69
160. Rustici G, Kolesnikov N, Brandizi M, Burdett T, Dylag M, et al. 2013. ArrayExpress update-trends in database growth and links to data analysis tools. Nucleic Acids Res. 41:D987-90